Great-West Lifeco Inc. (TSE:GWO - Free Report) - Stock analysts at National Bank Financial issued their Q2 2025 EPS estimates for shares of Great-West Lifeco in a research report issued to clients and investors on Wednesday, February 5th. National Bank Financial analyst G. Dechaine expects that the company will post earnings of $1.20 per share for the quarter. The consensus estimate for Great-West Lifeco's current full-year earnings is $4.45 per share. National Bank Financial also issued estimates for Great-West Lifeco's Q3 2025 earnings at $1.22 EPS, Q4 2025 earnings at $1.21 EPS, FY2025 earnings at $4.85 EPS and FY2026 earnings at $5.13 EPS.
Several other research analysts have also commented on the stock. Royal Bank of Canada boosted their price objective on shares of Great-West Lifeco from C$47.00 to C$51.00 in a research note on Friday, November 8th. Barclays boosted their price objective on shares of Great-West Lifeco from C$45.00 to C$46.00 in a research note on Monday, January 6th. CIBC upped their price target on shares of Great-West Lifeco from C$55.00 to C$56.00 in a research note on Thursday, January 30th. Scotiabank upgraded shares of Great-West Lifeco from a "hold" rating to a "strong-buy" rating in a research note on Monday. Finally, Jefferies Financial Group upped their price objective on shares of Great-West Lifeco from C$42.00 to C$48.00 and gave the company a "hold" rating in a report on Wednesday, October 16th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of C$47.88.
Check Out Our Latest Analysis on Great-West Lifeco
TSE:GWO opened at C$52.39 on Friday. Great-West Lifeco has a one year low of C$38.44 and a one year high of C$52.39. The company has a debt-to-equity ratio of 29.61, a quick ratio of 22.18 and a current ratio of 37.46. The firm has a market cap of C$48.83 billion, a P/E ratio of 13.16, a P/E/G ratio of 2.26 and a beta of 0.84. The firm has a 50-day simple moving average of C$47.29 and a 200-day simple moving average of C$45.94.
Great-West Lifeco (TSE:GWO - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported C$1.14 EPS for the quarter, beating the consensus estimate of C$1.08 by C$0.06. Great-West Lifeco had a net margin of 11.32% and a return on equity of 13.21%. During the same period last year, the company posted $1.00 earnings per share.
In related news, Senior Officer David Martin Harney sold 562 shares of the company's stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of C$47.55, for a total value of C$26,721.58. Also, Director Paul Mahon sold 146,826 shares of the company's stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of C$49.88, for a total value of C$7,323,842.39. In the last three months, insiders have sold 174,613 shares of company stock valued at $8,697,880. Insiders own 70.70% of the company's stock.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 31st. Investors of record on Tuesday, December 31st were paid a $0.555 dividend. The ex-dividend date of this dividend was Tuesday, December 3rd. This represents a $2.22 dividend on an annualized basis and a yield of 4.24%. Great-West Lifeco's payout ratio is 55.78%.
Great-West Lifeco Inc engages in the life and health insurance, retirement and investment services, asset management, and reinsurance businesses in Canada, the United States, and Europe. The company offers life, accidental death and dismemberment, disability, critical illness, health and dental protection, and creditor insurance products; and retirement and wealth savings, income and annuity products, and other specialty products to individuals, families, businesses, and organizations.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Great-West Lifeco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Great-West Lifeco wasn't on the list.
While Great-West Lifeco currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.